Scope of Research Program. (a) During the Research Program Term, the parties will collaborate in the discovery and development of Antigens for use in Vaccine(s) for the prevention and/or treatment of PC and any other tumor type in the Licensed Field to the extent those Antigens are useful for such tumor types. The program of activities to be conducted by Corixa and SB during the term of the Agreement is set forth in Exhibit D (the "Research Program"). No material deviation in the subject matter and scope of such Research Program shall be made without the mutual and written agreement of both parties.
Scope of Research Program. A detailed description and tentative time line for the Research Program and the first Annual Research Plan are attached hereto as Exhibit A.
Scope of Research Program. The Extension Term Research Plan for the Research Program is as set forth in Exhibit A, which is attached hereto and incorporated herein by reference.
Scope of Research Program. In addition to the Research Program under Original Agreement and Amendment No. 1, Icagen agrees to perform the research studies with the Additional Compound Samples, the details of which are set forth in the “Extended Research Plan for [**] Project” which is attached hereto as Exhibit I, and incorporated herein by reference.
Scope of Research Program. During the Research Term, the parties shall jointly collaborate in performing Research Projects, as adopted pursuant to Section 3.2 below. Such activities shall include all drug discovery disciplines from ROCHE and EVOTEC and responsibility therefore shall be allocated by the appropriate committee pursuant to Section 3 and according to the parties’ expertise. The details of the activities to be performed by either party within the Research Project(s) shall be specified within individual Research Plans to be agreed between the parties from time to time in the Joint Steering Committee. Unless otherwise stipulated in Section 5.5, each party shall bear its own costs for the activities performed by it under the Research Project. At the initiation of a Research Project, EVOTEC shall disclose to ROCHE the EVOTEC Compounds found to be active against the Target, in case of the first Research Project against Kv1.3.
Scope of Research Program. The Parties agree to undertake a Research Program for the pre-clinical development of the First Product, including use as a combination therapy, and for pre-clinical development of Future Products. The Joint Steering Committee shall prepare, or have prepared, and provide to each Party a detailed description, mutually acceptable to the Parties in form and substance, of the activities to be undertaken during each 12-month period during the Research Program, which shall include a reasonably detailed description of the goals and scope of such research, a corresponding detailed budget for each Party, the allocation of responsibilities to the respective Parties and a work plan, milestones and project target dates for such period (including the personnel, equipment and facilities that TOPOTARGET or CURAGEN is required to provide) (each such 12-month plan, as may be updated or modified from time to time, a “Research Plan”). The objective of the Research Plan will be to allow and support US IND submissions and submissions to governmental authorities of other countries as determined by the Joint Steering Committee concerning the First Product and Future Products. The initial Research Plan is attached as Exhibit C. Each subsequent Research Plan shall be embodied in a letter agreement to be executed by the Parties and shall be finalized at least thirty (30) days prior to the end of the prior twelve-month period. The Joint Steering Committee shall regularly review, update and, as necessary, modify each Research Plan from time to time. The Joint Steering Committee shall promptly provide each Party with any such updates or modifications.
Scope of Research Program. (a) As soon as practicable after the date of this Agreement (but in no event greater than 90 days thereafter), and on each anniversary of the date of this Agreement during the term of the Research Program, the Steering Committee shall prepare and provide to each Party, in form and substance mutually acceptable to each Party, a detailed description of the specific Research Program to be undertaken during the upcoming year, which shall include a reasonably detailed description of the goals and scope of such research, the allocation of responsibilities to the respective Parties and a research plan (an “Annual Research Plan”). While the Parties do not currently anticipate the need for further primary screening of any ICAgen Compounds, if, but only if, the Parties mutually determine, in their sole discretion, that as part of the Research Program, ICAgen shall screen additional ICAgen Compounds (which, in any event, shall not include Molecular Diversity Libraries), then the Steering Committee shall amend the Annual Research Plan for the year(s) during which such screening is to occur to include minimum criteria, acceptable to both Parties, for determination of ICAgen Compounds that constitute Collaboration Compounds. The Steering Committee shall commence preparing each Annual Research Plan (other than the first Annual Research Plan) not later three months prior to each anniversary of this Agreement during such term.
Scope of Research Program. (a) The Research Program is a program for collaborative research under which CADUS and SB will carry out the research agreed upon by the Parties directed at Targets during the term of the Research Program (as defined in Paragraph 3.8). SB has the right, under the Research Program, to have CADUS conduct research on [c.i.] during the initial term of the Research Program and [c.i.] any extension of the Research Program pursuant to Paragraph 3.8. Promptly after the Effective Date SB shall have the right to submit to CADUS [c.i.] confirmed or putative orphan G protein-coupled receptors for inclusion into the Research Program and such receptors shall be Targets provided they are not excluded or withdrawn as provided in this Section 3. SB shall have the right to replace any of such [c.i.] receptors which are excluded or withdrawn as provided in this Section 3.
Scope of Research Program. The Parties hereby agree to establish and conduct, during the Research Phase, a collaborative research program in the Field. The initial Research Plan for conducting such research program is attached hereto as Exhibit B. The Parties will collaborate in identifying and validating targets, developing and using screens based on such targets to identify, discover and/or synthesize Active Compounds, and performing such preclinical studies as are necessary in order for Allergan to select Collaboration Compounds for further testing and Development Compounds for clinical development into pharmaceutical products. The Research Program shall be conducted by CNSI and Allergan in good scientific manner, and in compliance with all applicable good laboratory practices and applicable legal requirements.
Scope of Research Program. The Joint Development Committee shall prepare and provide to each Party a detailed description, mutually acceptable to the Parties in form and substance, of the activities to be undertaken during each 12-month period during the Research Program, which shall include a reasonably detailed description of the goals and scope of such research, the allocation of responsibilities to the respective Parties and a work plan, milestones and project target dates for such period (including the personnel, equipment and facilities that OXiGENE is required to provide) (each such 12-month plan, as may be updated or modified from time to time, a "Research Plan"). Each Research Plan shall be embodied in a letter agreement to be executed by the Parties and shall include only projects ****** the ASU Licensed Technology. The Joint Development Committee shall agree upon the Research Plan for the first 12 months of the Research Program as promptly as possible after the Effective Date and, in any event, no later than 90 days thereafter. The Joint Development Committee shall regularly review, update and, as necessary, modify each Research Plan from time to time. The Joint Development Committee shall promptly provide each Party with any such updates or modifications.
